These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7738422)

  • 1. Molecular genetics of thrombophilia: factor V gene mutation causing resistance to activated protein C as a basis of the hypercoagulable state.
    Dahlbäck B
    J Lab Clin Med; 1995 May; 125(5):566-71. PubMed ID: 7738422
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to activated protein C and a novel factor V gene mutation.
    Voelkerding KV
    Clin Lab Med; 1996 Mar; 16(1):169-86. PubMed ID: 8867589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to activated protein C as risk factor for thrombosis: molecular mechanisms, laboratory investigation, and clinical management.
    Dahlbäck B
    Semin Hematol; 1997 Jul; 34(3):217-34. PubMed ID: 9241707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated protein C resistance--a major risk factor for thrombosis.
    Rosén SB; Sturk A
    Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):501-16. PubMed ID: 9263726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predisposition to thrombosis by a factor V mutation causing hereditary resistance to activated protein C.
    Press RD; Goodnight SH
    West J Med; 1995 May; 162(5):450-2. PubMed ID: 7785262
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V and protein S as cofactors to activated protein C.
    Dahlbäck B
    Haematologica; 1997; 82(1):91-5. PubMed ID: 9107093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activated protein C resistance: role in venous and arterial thrombosis].
    Emmerich J; Alhenc-Gelas M; Aiach M; Fiessinger JN
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):741-5. PubMed ID: 8760661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Activated protein C resistance as a cause of thrombophilia].
    Ruiz-Argüelles GJ
    Rev Invest Clin; 1996; 48(3):223-9. PubMed ID: 8966383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1995 Jul; 74(1):139-48. PubMed ID: 8578447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Factor V Leiden and activated protein C resistance].
    Cauchie P; Hilbert P
    Rev Med Brux; 1997 Jun; 18(3):97-102. PubMed ID: 9273603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to activated protein C caused by the R506Q mutation in the gene for factor V is a common risk factor for venous thrombosis.
    Dahlbck B
    J Intern Med Suppl; 1997; 740():1-8. PubMed ID: 9350175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Activated protein C resistance and mutation of coagulation factor V].
    Samama MM
    Arch Mal Coeur Vaiss; 1996 Jun; 89(6):669-70. PubMed ID: 8760650
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to activated protein C: a new etiology for hypercoagulable states.
    Yossepowitch O; Safadi R; Chajek-Shaul T
    Isr J Med Sci; 1995 Aug; 31(8):510-2. PubMed ID: 7635704
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of factor V Leiden mutation and other hereditary thrombophilic factors in Egyptian children with portal vein thrombosis: results of a single-center case-control study.
    El-Karaksy H; El-Koofy N; El-Hawary M; Mostafa A; Aziz M; El-Shabrawi M; Mohsen NA; Kotb M; El-Raziky M; El-Sonoon MA; A-Kader H
    Ann Hematol; 2004 Nov; 83(11):712-5. PubMed ID: 15309526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis.
    Dahlbäck B
    Thromb Haemost; 1997 Jul; 78(1):483-8. PubMed ID: 9198201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial thrombophilia: a complex genetic disorder.
    Koeleman BP; Reitsma PH; Bertina RM
    Semin Hematol; 1997 Jul; 34(3):256-64. PubMed ID: 9241710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A new hereditary cause of portal vein thrombosis: the abnormal resistance to activated protein C by the Arg 506-->Gln mutation of the gene of factor V].
    Levoir D; Aubertin JM; Alhenc-Gelas M; Bloch F; Becheur H; Petite JP
    Gastroenterol Clin Biol; 1995; 19(8-9):729-31. PubMed ID: 8522125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activated protein C resistance syndrome].
    Souto JC; Fontcuberta J
    Sangre (Barc); 1997 Dec; 42(6):453-66. PubMed ID: 9490910
    [No Abstract]   [Full Text] [Related]  

  • 20. Coagulation factor V and thrombophilia: background and mechanisms.
    Segers K; Dahlbäck B; Nicolaes GA
    Thromb Haemost; 2007 Sep; 98(3):530-42. PubMed ID: 17849041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.